Literature DB >> 29635415

Beyond the Biomedical: Preexposure Prophylaxis Failures in a Cohort of Young Black Men Who Have Sex With Men in Atlanta, Georgia.

David P Serota1, Eli S Rosenberg2, Annie M Lockard3, Charlotte-Paige M Rolle4,5, Nicole Luisi3, Scott Cutro6, Carlos Del Rio1,5, Aaron J Siegler3, Travis H Sanchez3, Patrick S Sullivan3, Colleen F Kelley1.   

Abstract

Human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) has high biomedical efficacy; however, awareness, access, uptake, and persistence on therapy remain low among black men who have sex with men (BMSM), who are at highest risk of HIV in the United States. To date, discussions of "PrEP failure" have focused on one typology: rare, documented HIV acquisitions among PrEP users with adequate serum drug levels (ie, biomedical failure). In our cohort of HIV-negative young BMSM in Atlanta, Georgia, we continue to observe a high HIV incidence (6.2% annually at interim analysis) despite access to free PrEP services. Among 14 seroconversions, all were offered PrEP before acquiring HIV. Among these participants, we identified 4 additional typologies of PrEP failure that expand beyond biomedical failure: low PrEP adherence, PrEP discontinuation, PrEP contemplation without initiation, and PrEP refusal. We describe the 5 typologies and suggest interventions to improve PrEP effectiveness among those at highest risk.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29635415      PMCID: PMC6117441          DOI: 10.1093/cid/ciy297

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

2.  Pre-exposure prophylaxis failure with tenofovir disoproxil.

Authors:  Hendrik Streeck; Jens Verheyen; Julian Storim; Ulf Dittmer; Christoph Jochum; Jörg Timm; Stefan Esser
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

3.  Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis.

Authors:  David C Knox; Peter L Anderson; P Richard Harrigan; Darrell H S Tan
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

4.  Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure.

Authors:  Kevin P Delaney; Debra L Hanson; Silvina Masciotra; Steven F Ethridge; Laura Wesolowski; Sherry Michele Owen
Journal:  Clin Infect Dis       Date:  2016-10-12       Impact factor: 9.079

5.  Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.

Authors:  Constance Delaugerre; Guillemette Antoni; Nadia Mahjoub; Gilles Pialoux; Eric Cua; Armelle Pasquet; Nolwenn Hall; Cécile Tremblay; Laurent Cotte; Catherine Capitant; Marie-Laure Chaix; Laurence Meyer; Jean-Michel Molina
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

6.  The Importance of Sexual History Taking for PrEP Comprehension Among Young People of Color.

Authors:  Sarit A Golub; Kristi E Gamarel; Corina Lelutiu-Weinberger
Journal:  AIDS Behav       Date:  2017-05

7.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

8.  PrEP Chicago: A randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men.

Authors:  Lindsay E Young; Phil Schumm; Leigh Alon; Alida Bouris; Matthew Ferreira; Brandon Hill; Aditya S Khanna; Thomas W Valente; John A Schneider
Journal:  Clin Trials       Date:  2017-09-01       Impact factor: 2.486

9.  Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014.

Authors:  Brooke E Hoots; Teresa Finlayson; Lina Nerlander; Gabriela Paz-Bailey
Journal:  Clin Infect Dis       Date:  2016-06-09       Impact factor: 9.079

10.  Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports.

Authors:  Julie Fox; Michael Brady; Hannah Alexander; Olubanke Davies; Nicola Robinson; Mathew Pace; Laura Else; John Cason; Saye Khoo; David Back; Sarah Fidler; John Frater
Journal:  Infect Dis Ther       Date:  2016-01-09
View more
  30 in total

1.  The Unanticipated Benefits of PrEP for Young Black Gay, Bisexual, and Other Men Who Have Sex with Men.

Authors:  Katherine G Quinn; Erika Christenson; Mark T Sawkin; Elizabeth Hacker; Jennifer L Walsh
Journal:  AIDS Behav       Date:  2020-05

Review 2.  Implementation Strategies to Increase PrEP Uptake in the South.

Authors:  Patrick S Sullivan; Leandro Mena; Latesha Elopre; Aaron J Siegler
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.071

3.  Rectal Douching and Microbicide Acceptability among Young Men who Have Sex with Men.

Authors:  Ryan C Tingler; Daniel Connochie; José A Bauermeister
Journal:  AIDS Behav       Date:  2020-05

4.  High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application.

Authors:  Matthew A Spinelli; Hyman M Scott; Eric Vittinghoff; Albert Y Liu; Kenneth Coleman; Susan P Buchbinder
Journal:  Sex Transm Dis       Date:  2019-04       Impact factor: 2.830

5.  Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States.

Authors:  Aaron J Siegler; Anna Bratcher; Kevin M Weiss
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

6.  Out-of-pocket costs and HIV pre-exposure prophylaxis persistence in a US multicity demonstration project.

Authors:  Nathan W Furukawa; John A Schneider; Megan E Coleman; Jeffrey B Wiener; Ram K Shrestha; Dawn K Smith
Journal:  Health Serv Res       Date:  2020-03-20       Impact factor: 3.402

7.  Advancing Novel PrEP Products - Alternatives to Non-Inferiority.

Authors:  David V Glidden
Journal:  Stat Commun Infect Dis       Date:  2019-08-06

8.  Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System.

Authors:  Matthew A Spinelli; Hyman M Scott; Eric Vittinghoff; Albert Y Liu; Alicia Morehead-Gee; Rafael Gonzalez; Monica Gandhi; Susan P Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

9.  Understanding PrEP Persistence: Provider and Patient Perspectives.

Authors:  Nicole D Laborde; Patrick M Kinley; Matthew Spinelli; Eric Vittinghoff; Ryan Whitacre; Hyman M Scott; Susan P Buchbinder
Journal:  AIDS Behav       Date:  2020-09

10.  Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California.

Authors:  Julia L Marcus; Leo B Hurley; Dennis Dentoni-Lasofsky; Courtney G Ellis; Michael J Silverberg; Sally Slome; Jonathan M Snowden; Jonathan E Volk
Journal:  AIDS Care       Date:  2018-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.